VistaGen Therapeutics Inc

NASDAQ:VTGN  
2.14
+0.01 (+0.47%)
4:11:40 PM EDT: $2.03 -0.11 (-5.14%)
Equity Financing / Related

Vistagen Therapeutics Announces Pricing Of Underwritten Public Offering

Published: 12/18/2020 12:59 GMT
VistaGen Therapeutics Inc (VTGN) - Vistagen Therapeutics Announces Pricing of Underwritten Public Offering.
Vistagen Therapeutics Inc - Pricing Offering of 63 Million Shares at $0.92/share and 2 Million Shares of Series D Convertible Preferred Stock at $21.16/share.
Vistagen Therapeutics Inc - Gross Proceeds From Offering Are Expected to Be $100 Million.